Drug for preventing respiratory infectious diseases

A technology of infectious diseases and respiratory tract, applied in respiratory system diseases, anti-infective drugs, drug combinations, etc., can solve problems such as large side effects, reduce the patient's physique and immunity, damage the patient's health, etc., and achieve a reasonable configuration effect.

Inactive Publication Date: 2017-07-04
岳乃余
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Among them, diseases such as tuberculosis, influenza, and atypical pneumonia are all called respiratory infectious diseases. At present, Western medicine is basically used to

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] A kind of medicament for preventing respiratory infectious disease, its component comprises by weight:

[0020] 4 parts of Ophiopogon japonicus, 5 parts of Digupi, 6 parts of Atractylodes macrocephala, 4 parts of dried blood, 6 parts of safflower, 3 parts of Yinhua, 3 parts of forsythia, 3 parts of Radix Radix, 1 part of Bupleurum, 2.5 parts of Scutellaria, 6 parts of almond 11 parts of Dangshen, 6 parts of Chenpi, 12 parts of Houttuynia, 6 parts of Chuan Lian, 3 parts of Imperata Rhizome, 3 parts of Radix Paeoniae Rubra, 3 parts of Dan Cortex, 1.5 parts of Licorice Root, 2.5 parts of Angelica, 3 parts of Coptidis Rhizoma, 2.5 parts of Phellodendron Phellodendri 2.5 parts of Rehmannia, 1 part of Schisandra, 2 parts of Rehmannia, 2 parts of Scrophulariaceae, 10 parts of mulberry leaves, and 6.5 parts of Campanulaceae.

Embodiment 2

[0022] A kind of medicament for preventing respiratory infectious disease, its component comprises by weight:

[0023] 7 parts of Ophiopogon japonicus, 8 parts of Digupi, 8 parts of Atractylodes macrocephala, 6 parts of dried blood, 8 parts of safflower, 6 parts of silver flower, 6 parts of forsythia, 6 parts of Radix Radix, 3 parts of Bupleurum, 5 parts of skullcap, 8 parts of almond 13 parts of Dangshen, 8 parts of Chenpi, 16 parts of Houttuynia cordata, 6 parts of Chuan Lian, 5 parts of Imperata rhizome, 5 parts of red peony root, 5 parts of paeonol, 3 parts of licorice, 5 parts of angelica, 6 parts of Coptis chinensis, and 5 parts of Cortex Phellodendri 5 parts of rehmannia, 3 parts of schisandra, 5 parts of raw land, 5 parts of Scrophulariaceae, 15 parts of mulberry leaves, and 8 parts of bellflower.

Embodiment 3

[0025] A kind of medicament for preventing respiratory infectious disease, its component comprises by weight:

[0026] 12 parts of Ophiopogon japonicus, 12 parts of Digupi, 12 parts of Atractylodes macrocephala, 9 parts of blood, 12 parts of safflower, 8 parts of Yinhua, 8 parts of forsythia, 8 parts of Radix Radix, 4 parts of Bupleurum, 7 parts of Scutellaria, 10 parts of almonds 15 parts of Dangshen, 10 parts of Chenpi, 23 parts of Houttuynia cordata, 10 parts of Chuanlian, 8 parts of Imperata Rhizome, 8 parts of red peony root, 8 parts of paeonol, 4 parts of licorice, 8 parts of angelica, 8 parts of coptis, and 8 parts of Cortex Phellodendri 8 parts of rehmannia, 4 parts of schisandra, 8 parts of raw land, 8 parts of Scrophulariaceae, 15 parts of mulberry leaves, and 10 parts of bellflower.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a drug for preventing respiratory infectious diseases. The drug comprises the following components in parts by weight: 4 to 15 parts of tuber of dwarf lilyturf, 5 to 16 parts of cortex lycii, 5 to 15 parts of bighead atractylodes rhizome, 2 to 12 parts of dragon's blood, 5 to 15 parts of safflower, 2 to 10 parts of honeysuckle flower, 2 to 10 parts of fructus forsythiae, 2 to 13 parts of isatis root, 1 to 6 parts of radix bupleuri, 2 to 10 parts of radix scutellariae, 6 to 12 parts of apricot kernel, 10 to 18 parts of radix codonopsis, and 2 to 13 parts of imperata rhizome. The formula of the drug is reasonable. The drug has a prominent preventive effect on respiratory infectious diseases, and the effect is long lasting. Moreover, the drug does not have any side or toxic effect. The drug dependency is not generated even if the patients take the drug for a long term.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a medicine for preventing respiratory infectious diseases. Background technique [0002] Respiratory tract infectious diseases refer to infectious diseases caused by the invasion of pathogens from the human body's nasal cavity, throat, trachea and bronchi and other respiratory infections. Common influenza, measles, chickenpox, rubella, meningitis, mumps, tuberculosis and so on. [0003] Among them, diseases such as tuberculosis, influenza, and atypical pneumonia are all called respiratory infectious diseases. At present, Western medicine is basically used to treat or prevent the above diseases. Western medicine has large side effects, which greatly damages the patient's health and reduces the patient's physical fitness and immunity Lili. To this end, we propose a drug for the prevention of respiratory infectious diseases. Contents of the invention [00...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/899A61P11/00A61P31/00
Inventor 岳乃余谭瑞臻邓文琦
Owner 岳乃余
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products